Current and historical daily PE Ratio for Lantheus Holdings Inc (
) from 2015 to May 14 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Lantheus stock (LNTH) PE ratio as of May 14 2024 is 12.07.
More Details
Lantheus Holdings Inc (LNTH) PE Ratio (TTM) Chart
Lantheus Holdings Inc (LNTH) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1228
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Lantheus PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-14 | 12.1 | 2024-03-11 | 13.5 |
| 2024-05-13 | 11.9 | 2024-03-08 | 13.5 |
| 2024-05-10 | 11.6 | 2024-03-07 | 13.5 |
| 2024-05-09 | 11.6 | 2024-03-06 | 13.4 |
| 2024-05-08 | 11.4 | 2024-03-05 | 13.9 |
| 2024-05-07 | 11.6 | 2024-03-04 | 14.1 |
| 2024-05-06 | 11.5 | 2024-03-01 | 13.9 |
| 2024-05-03 | 11.5 | 2024-02-29 | 14.1 |
| 2024-05-02 | 11.9 | 2024-02-28 | 14.1 |
| 2024-05-01 | 10.3 | 2024-02-27 | 14.7 |
| 2024-04-30 | 10.2 | 2024-02-26 | 14.7 |
| 2024-04-29 | 10.3 | 2024-02-23 | 14.3 |
| 2024-04-26 | 10.0 | 2024-02-22 | 14.0 |
| 2024-04-25 | 9.9 | 2024-02-21 | 12.2 |
| 2024-04-24 | 10.0 | 2024-02-20 | 12.3 |
| 2024-04-23 | 9.8 | 2024-02-16 | 12.4 |
| 2024-04-22 | 9.6 | 2024-02-15 | 12.4 |
| 2024-04-19 | 9.7 | 2024-02-14 | 12.2 |
| 2024-04-18 | 9.5 | 2024-02-13 | 11.8 |
| 2024-04-17 | 9.4 | 2024-02-12 | 12.2 |
| 2024-04-16 | 9.4 | 2024-02-09 | 12.1 |
| 2024-04-15 | 9.2 | 2024-02-08 | 12.0 |
| 2024-04-12 | 9.3 | 2024-02-07 | 11.8 |
| 2024-04-11 | 9.4 | 2024-02-06 | 11.8 |
| 2024-04-10 | 9.1 | 2024-02-05 | 11.7 |
| 2024-04-09 | 9.2 | 2024-02-02 | 11.6 |
| 2024-04-08 | 9.1 | 2024-02-01 | 11.4 |
| 2024-04-05 | 9.3 | 2024-01-31 | 11.2 |
| 2024-04-04 | 9.1 | 2024-01-30 | 11.5 |
| 2024-04-03 | 9.0 | 2024-01-29 | 11.6 |
| 2024-04-02 | 9.0 | 2024-01-26 | 11.4 |
| 2024-04-01 | 9.2 | 2024-01-25 | 11.3 |
| 2024-03-28 | 9.5 | 2024-01-24 | 11.0 |
| 2024-03-27 | 13.0 | 2024-01-23 | 11.3 |
| 2024-03-26 | 12.7 | 2024-01-22 | 11.8 |
| 2024-03-25 | 12.7 | 2024-01-19 | 11.4 |
| 2024-03-22 | 12.7 | 2024-01-18 | 11.9 |
| 2024-03-21 | 12.7 | 2024-01-17 | 11.9 |
| 2024-03-20 | 12.8 | 2024-01-16 | 11.9 |
| 2024-03-19 | 12.6 | 2024-01-12 | 12.1 |
| 2024-03-18 | 12.2 | 2024-01-11 | 12.3 |
| 2024-03-15 | 12.5 | 2024-01-10 | 12.8 |
| 2024-03-14 | 12.9 | 2024-01-09 | 13.6 |
| 2024-03-13 | 12.9 | 2024-01-08 | 14.1 |
| 2024-03-12 | 13.1 | 2024-01-05 | 13.9 |
Lantheus Holdings Inc (LNTH) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Lantheus Holdings Inc
NAICS : 325411
SIC : 2834
ISIN : US5165441032
Description
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers